Description
A KAT II inhibitor (IC50s = 0.032 and 0.263 µM for human and rat recombinant enzymes, respectively); selective for KAT II over KAT I, -III, and -IV (IC50s = 21.6, 107, and >50 µM, respectively); reduces basal striatum, prefrontal cortex, and hippocampus kynurenic acid levels in rats at 10 mg/kg; prevents ketamine- or amphetamine-induced disruption of auditory gating in rats, as well as prevents ketamine-induced deficits in spatial memory in non-human primates; inhibits GOT1 (IC50 = 8 µM); reduces the viability of PaTu 8988t and PaTu 8902 pancreatic cancer cells
Formal name: (3S)-3-amino-3,4-dihydro-1-hydroxy-2(1H)-quinolinone, monohydrochloride
Synonyms:
Molecular weight: 214.7
CAS: 177943-33-8
Purity: ≥98%
Formulation: A solid